🔴 IDEXX is trading 9% down in pre-market with no clear company-specific catalyst identified

IDEXX is trading 9.22% down at $510.99 in pre-market on October 29, with no clear company-specific announcement explaining the move.

• IDEXX is scheduled to report third-quarter results on November 2; earnings are upcoming, not a reported overnight catalyst.
• UBS cut its price target to $627 from $670 in coverage reported October 27, but available coverage does not establish it as the cause of the pre-market decline.
• Healthcare is up in the supplied sector context and does not explain the stock’s drop.